{{Rsnum
|rsid=4396880
|Gene=TP63
|Chromosome=3
|position=189638432
|Orientation=plus
|GMAF=0.3338
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TP63
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 38.9 | 43.4
| HCB | 9.5 | 42.3 | 48.2
| JPT | 7.1 | 46.0 | 46.9
| YRI | 8.2 | 36.7 | 55.1
| ASW | 3.5 | 33.3 | 63.2
| CHB | 9.5 | 42.3 | 48.2
| CHD | 7.4 | 35.2 | 57.4
| GIH | 7.9 | 35.6 | 56.4
| LWK | 8.2 | 48.2 | 43.6
| MEX | 7.0 | 29.8 | 63.2
| MKK | 3.9 | 29.2 | 66.9
| TSI | 16.7 | 44.1 | 39.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=21610222
|Title=Variation in TP63 is associated with lung adenocarcinoma in the UK population
}}

{{PMID Auto
|PMID=19521098
|Title=Genome scan, fine-mapping, and candidate gene analysis of non-syndromic cleft lip with or without cleft palate reveals phenotype-specific differences in linkage and association results.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}